y 27632 has been researched along with Progeria in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, HJC; Choi, K; Jung, CW; Kang, HT; Kim, GR; Lee, YS; Park, JT; Park, SC | 1 |
Cho, KA; Kang, HT; Lee, YS; Park, CH; Park, JT; Park, SC | 1 |
2 other study(ies) available for y 27632 and Progeria
Article | Year |
---|---|
Chemical screening identifies ROCK as a target for recovering mitochondrial function in Hutchinson-Gilford progeria syndrome.
Topics: Amides; Amino Acid Sequence; Cells, Cultured; Cytochromes c; DNA Breaks, Double-Stranded; Fibroblasts; Gene Expression Regulation; HEK293 Cells; High-Throughput Screening Assays; Humans; Mitochondria; Phosphorylation; Progeria; Protein Binding; Protein Kinase Inhibitors; Pyridines; rac1 GTP-Binding Protein; Reactive Oxygen Species; rho-Associated Kinases; Sequence Alignment; Sequence Homology, Amino Acid; Signal Transduction; Two-Hybrid System Techniques | 2017 |
A crucial role of ROCK for alleviation of senescence-associated phenotype.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Cell Proliferation; Cellular Senescence; Child; Chromatin; Fibroblasts; Humans; Male; Mice; Mice, Inbred C57BL; Phenotype; Progeria; Pyridines; rho-Associated Kinases; Wound Healing | 2018 |